LIVAGEN 20MG

New
LIVAGEN 20MG
$70.00 $62.00

Livagen | 20mg | Synthetic Cytomedin Peptide

For In Vitro Research Use Only — Not for Human or Veterinary Use

Description:

Livagen is a cytomedin peptide studied for its potential effects on hepatic cellular activity, metabolic enzyme regulation, detoxification pathways, and tissue-regeneration mechanisms within in vitro liver research models.

As a peptide associated with hepatocyte-support studies, Livagen is frequently used to investigate oxidative balance, gene-expression control, and mitochondrial activity in metabolic tissues. This vial contains 20mg of lyophilized Livagen peptide for advanced laboratory use.

Specifications:

  • Unit Size: 20mg (lyophilized powder, single vial)
  • Form: Crystalline lyophilized peptide
  • Solubility: Soluble in sterile water or aqueous buffer
  • Storage: Store dry at 2°C–8°C. After reconstitution, refrigerate and use within 10–14 days.

Application Context:

Livagen is researched in vitro for potential roles in:

  • Hepatic metabolic regulation

  • Detoxification and oxidative balance

  • Tissue-regeneration and liver-cell recovery

  • Gene-expression pathways in hepatocyte models

Intended Use:
This compound is intended strictly for in vitro laboratory research. It is not approved for human or animal use and must not be incorporated into food, cosmetics, supplements, or pharmaceuticals.